GSK shares dive as weaker vaccine sales unnerve investors
British pharma company one of biggest fallers on FTSE 100 despite better than expected financial results Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better than expected financial results, as investors were unnerved by weaker sales of its respiratory syncytial virus (RSV) and shingles vaccines and recently launched medications. Britain’s second-biggest…
వార్త సారాంశం
British pharma company one of biggest fallers on FTSE 100 despite better than expected financial results Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better than expected financial results, as investors were unnerved by weaker sales of its respiratory syncytial virus (RSV) and shingles vaccines and recently launched medications. Britain’s second-biggest…
నమ్మకమైన ప్రచురణకర్తల తాజా వార్తలను సంక్షిప్త సారాంశాలతో చదవండి. వివరాల కోసం అసలు మూల లింక్ను తెరవండి.